Iovance Biotherapeutics, Inc.

The current price of IOVA is 11.86 USD — it has increased by 4.77% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Iovance Biotherapeutics, Inc. stocks are traded under the ticker IOVA.

Iovance Biotherapeutics, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.

IOVA stock is 5.70% volatile and has beta coefficient of 3.21. Check out the list of the most volatile stocks — is Iovance Biotherapeutics, Inc. there?

IOVA earnings for the last quarter are −0.46 USD per share, whereas the estimation was −0.45 USD resulting in a −1.18% surprise. The estimated earnings for the next quarter are −0.43 USD per share. See more details about Iovance Biotherapeutics, Inc. earnings.

Iovance Biotherapeutics, Inc. revenue for the last quarter amounts to ‪469.00 K‬ USD despite the estimated figure of ‪4.50 M‬ USD. In the next quarter revenue is expected to reach ‪1.44 M‬ USD.

Yes, you can track Iovance Biotherapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

IOVA stock has risen by 0.59% compared to the previous week, the month change is a 22.15% fall, over the last year Iovance Biotherapeutics, Inc. has showed a 105.90% increase.

Today Iovance Biotherapeutics, Inc. has the market capitalization of ‪3.16 B‬, it has decreased by 7.50% over the last week.

No, IOVA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, IOVA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Iovance Biotherapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

IOVA reached its all-time high on Jun 7, 2011 with the price of 165.00 USD, and its all-time low was 1.01 USD and was reached on May 3, 2013.
See other stocks reaching their highest and lowest prices.

As of Apr 23, 2024, the company has 557.00 employees. See our rating of the largest employees — is Iovance Biotherapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Iovance Biotherapeutics, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Iovance Biotherapeutics, Inc. stock shows the neutral signal. See more of Iovance Biotherapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Iovance Biotherapeutics, Inc. future price: according to them, IOVA price has a max estimate of 34.00 USD and a min estimate of 19.00 USD. Read a more detailed Iovance Biotherapeutics, Inc. forecast: see what analysts think of Iovance Biotherapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Iovance Biotherapeutics, Inc. EBITDA is ‪−427.43 M‬ USD, and current EBITDA margin is ‪−35.95 K‬%. See more stats in Iovance Biotherapeutics, Inc. financial statements.